Windward Bio Group AG WWB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $30.04
- Day Range
- $22.55–27.51
- 52-Week Range
- $18.47–33.75
- Bid/Ask
- $24.90 / $25.30
- Shares Outstanding
- 58.04M
- Market Cap
- $1.46B
- Volume/Avg
- 210,250 / 760,202
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Windward Bio Group AG is a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, COPD, and atopic dermatitis. Its flagship program is WIN378, a potentially novel, long-acting, anti-TSLP monoclonal antibody. The pipeline also includes WIN027, a clinical-stage, long-acting anti-TSLPxIL-13 bi-specific, which has therapeutic application across immunological diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.windwardbio.com
Valuation
Metric | WWB |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | WWB |
|---|---|
Quick Ratio | 8.49 |
Current Ratio | 8.57 |
Interest Coverage | −6,842.30 |
Quick Ratio
WWB
Profitability
Metric | WWB |
|---|---|
Return on Assets (Normalized) | −24.26% |
Return on Equity (Normalized) | −27.01% |
Return on Invested Capital (Normalized) | −27.04% |
Return on Assets
WWB
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|#p?DB?> | LOCK|?^%J | $136B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|SF$xdX | LOCK|@N&#t | $99B | |||
| Moderna Inc MRNA | LOCK|n^Q!Lt$ | LOCK|W& | $87B | |||
| argenx SE ADR ARGX | LOCK|>c&%h%& | LOCK|$$z | $61B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|Fct^n? | LOCK|&k! | $48B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|<>^%&V$ | LOCK|!sG<L | $31B | |||
| Incyte Corp INCY | LOCK|^w^X@> | LOCK|PF | $25B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|PrtLFS! | LOCK|zwT> | $21B | |||
| BioNTech SE ADR BNTX | LOCK|>tS&<Lm | LOCK|Jw | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|SK%<^N$ | LOCK|WM? | $15B |